I.M. Sechenov First Moscow State Medical University, Center for Clinical Studies of Medicinal Products
I.M. Sechenov First Moscow State Medical University, Center for Clinical Studies of Medicinal Products
Moscow, Russia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) | Skin and Connective Tissue Diseases, connective tissue disorder, muscle tissue disorder, musculoskeletal system disorder, polymyalgia rheumatica, rheumatic disorder | Active, not recruiting | Phase 3 | 2026-06-30 | NCT07670546 |